Integrase-defective lentiviral-vector-based vaccine: a new vector for induction of T cell immunity

被引:29
作者
Negri, Donatella R. M. [1 ]
Michelini, Zuleika [2 ]
Bona, Roberta [2 ]
Blasi, Maria [3 ]
Filati, Piero [2 ]
Leone, Pasqualina [2 ]
Rossi, Alessandra [1 ]
Franco, Marina [2 ]
Cara, Andrea [2 ]
机构
[1] Ist Super Sanita, Dept Infect Parasit & Immune Mediated Dis, I-00161 Rome, Italy
[2] Ist Super Sanita, Dept Therapeut Res & Med Evaluat, I-00161 Rome, Italy
[3] Ist Super Sanita, Dept Cell Biol & Neurosci, I-00161 Rome, Italy
关键词
HIV-1; integrase; integrase inhibitors; lentiviral vector; T cell immunity; vaccine; SIMIAN IMMUNODEFICIENCY VIRUS; GENE-TRANSFER; DENDRITIC CELLS; HIV-INTEGRASE; IN-VIVO; PERSISTENT TRANSCRIPTION; INTRANASAL DELIVERY; NONDIVIDING CELLS; EPISOMAL VECTORS; NASAL EPITHELIA;
D O I
10.1517/14712598.2011.571670
中图分类号
Q81 [生物工程学(生物技术)]; Q93 [微生物学];
学科分类号
071005 ; 0836 ; 090102 ; 100705 ;
摘要
Areas covered: In this review we describe the development and application of IDLV for vaccination. IDLV are turning out to be a new class of vectors endowed with peculiar characteristics, setting them apart from the parental integration-competent lentiviral vectors. Recent data suggest that IDLV are able to induce strong antigen-specific immune responses in terms of quantity, persistence and quality of CD8<SU++</SU T cell response following a single immunization in mice. Expert opinion: IDLV are a recent acquisition in the field of genetic immunization, thus allowing for the opportunity of further upgrading, including increasing antigen expression and potency of immune response. Based on recent reports showing the potential of IDLV for immunization in mouse models, further development and validation of IDLV, including comparison with other vaccine protocols and use in non-human primate models, are warranted.
引用
收藏
页码:739 / 750
页数:12
相关论文
共 99 条
[1]  
[Anonymous], 2015, GENE THERAPY CLIN TR
[2]   Stable gene transfer to muscle using non-integrating lentiviral vectors [J].
Apolonia, Luis ;
Waddington, Simon N. ;
Fernandes, Carolina ;
Ward, Natalie J. ;
Bouma, Gerben ;
Blundell, Michael P. ;
Thrasher, Adrian J. ;
Collins, Mary K. ;
Philpott, Nicola J. .
MOLECULAR THERAPY, 2007, 15 (11) :1947-1954
[3]   Lentiviral Vectors Transduce Proliferating Dendritic Cell Precursors Leading to Persistent Antigen Presentation and Immunization [J].
Arce, Frederick ;
Rowe, Helen M. ;
Chain, Benjamin ;
Lopes, Luciene ;
Collins, Mary K. .
MOLECULAR THERAPY, 2009, 17 (09) :1643-1650
[4]   Proinflammatory responses in the murine brain after intranasal delivery of cholera toxin: Implications for the use of AB toxins as adjuvants in intranasal vaccines [J].
Armstrong, ME ;
Lavelle, EC ;
Loscher, CE ;
Lynch, MA ;
Mills, KHG .
JOURNAL OF INFECTIOUS DISEASES, 2005, 192 (09) :1628-1633
[5]  
Arya Suresh K, 2003, Methods Mol Biol, V229, P219
[6]   Human gene therapy vectors derived from feline lentiviruses [J].
Barraza, Roman A. ;
Poeschla, Eric M. .
VETERINARY IMMUNOLOGY AND IMMUNOPATHOLOGY, 2008, 123 (1-2) :23-31
[7]   A Large U3 Deletion Causes Increased In Vivo Expression From a Nonintegrating Lentiviral Vector [J].
Bayer, Matthew ;
Kantor, Boris ;
Cockrell, Adam ;
Ma, Hong ;
Zeithaml, Brian ;
Li, Xiangping ;
McCown, Thomas ;
Kafri, Tal .
MOLECULAR THERAPY, 2008, 16 (12) :1968-1976
[8]   Lentiviral Vector-Based Prime/Boost Vaccination against AIDS: Pilot Study Shows Protection against Simian Immunodeficiency Virus SIVmac251 Challenge in Macaques [J].
Beignon, Anne-Sophie ;
Mollier, Karine ;
Liard, Christelle ;
Coutant, Frederic ;
Munier, Sandie ;
Riviere, Julie ;
Souque, Philippe ;
Charneau, Pierre .
JOURNAL OF VIROLOGY, 2009, 83 (21) :10963-10974
[9]   SIVMAC Vpx improves the transduction of dendritic cells with nonintegrative HIV-1-derived vectors [J].
Berger, G. ;
Goujon, C. ;
Darlix, J-L ;
Cimarelli, A. .
GENE THERAPY, 2009, 16 (01) :159-163
[10]   Gene transfer systems derived from visna virus: Analysis of virus production and infectivity [J].
Berkowitz, RD ;
Ilves, H ;
Plavec, I ;
Veres, G .
VIROLOGY, 2001, 279 (01) :116-129